Clinical Diagnostics remains the most crucial and largest application segment in the Polymerase Chain Reaction (PCR) Market, expected to hold a significant market share (upwards of 44% by 2035).

• Infectious Disease Testing: The high specificity and sensitivity of Polymerase Chain Reaction make it the standard method for identifying infectious agents, including bacteria, viruses, and fungi. The market experienced massive growth due to the SARS-CoV-2 pandemic, which normalized high-volume PCR testing in public health and clinical laboratory workflows. Continued reliance on PCR for routine screening and outbreak control for conditions like HIV, Hepatitis B/C, and hospital-acquired infections ensures its dominance.

• High-Throughput Labs: The rising complexity and volume of testing have driven diagnostic laboratories to adopt automated, high-throughput PCR systems, reducing manual errors and improving turnaround times, thereby further accelerating the adoption of this technology in hospital and independent diagnostic labs globally.

Reference: https://www.marketresearchfuture.com/reports/polymerase-chain-reaction-market-19212